Skip to main content
Premium Trial:

Request an Annual Quote

Frank Ingari

Cure Forward has appointed Frank Ingari as CEO. He has more than 35 years of experience in the consumer, healthcare, and information technology industries. Ingari comes to Cure Forward, from NaviNet where he served as CEO. He has also held CEO appointments at 5-Star Medicare Advantage plan Essence Healthcare and best-in-KLAS value-based care service provider Lumeris, which Ingari co-founded.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.